Integral Health Asset Management, LLC
Q3 2026 13F filing
Updated 6 days ago97 disclosed positions worth $1.6B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | R REVOLUTION MEDICINES INC | $130.3M | 1.00M | 7.91% | — |
| 2 | I INSMED INC | $129M | 1.60M | 7.83% | — |
| 3 | E EDGEWISE THERAPEUTICS INC | $97.4M | 2.40M | 5.92% | — |
| 4 | C CYTOKINETICS INC | $72.5M | 1.60M | 4.40% | — |
| 5 | M MERCK & CO INC | $65.4M | 450.0K | 3.97% | — |
| 6 | S SCHOLAR ROCK HLDG CORP | $60.6M | 1.25M | 3.68% | — |
| 7 | C CENTENE CORP DEL | $46.6M | 750.0K | 2.83% | — |
| 8 | A AXSOME THERAPEUTICS INC. | $46.1M | 250.0K | 2.80% | — |
| 9 | V VERA THERAPEUTICS INC | $32.3M | 1.50M | 1.96% | — |
| 10 | A AMGEN INC | $31.6M | 75.0K | 1.92% | — |
| 11 | L LIFESTANCE HEALTH GROUP INC | $31.3M | 2.60M | 1.90% | — |
| 12 | R REGENERON PHARMACEUTICALS | $30.3M | 40.0K | 1.84% | — |
| 13 | T TENET HEALTHCARE CORP | $23M | 90.0K | 1.40% | — |
| 14 | B BIOGEN INC | $22.6M | 100.0K | 1.37% | — |
| 15 | T TANGO THERAPEUTICS INC | $22.5M | 1.00M | 1.36% | — |
| 16 | C CARDINAL HEALTH INC | $22.3M | 100.0K | 1.35% | — |
| 17 | C CVS HEALTH CORP | $21.4M | 500.0K | 1.30% | — |
| 18 | N NEUROCRINE BIOSCIENCES INC | $21.3M | 150.0K | 1.29% | — |
| 19 | V VERTEX PHARMACEUTICALS INC | $20.9M | 40.0K | 1.27% | — |
| 20 | O ORIC PHARMACEUTICALS INC | $20.2M | 1.70M | 1.23% | — |
| 21 | B BRIDGEBIO PHARMA INC | $19.7M | 300.0K | 1.20% | — |
| 22 | I INCYTE CORP | $19.4M | 160.0K | 1.18% | — |
| 23 | D DEFINIUM THERAPEUTICS INC | $19M | 500.0K | 1.16% | — |
| 24 | B BRIGHTSPRING HEALTH SVCS INC | $18.4M | 325.0K | 1.12% | — |
| 25 | B BEONE MEDICINES LTD | $18.3M | 50.0K | 1.11% | — |
| 26 | R ROIVANT SCIENCES LTD | $18.3M | 2.00M | 1.11% | — |
| 27 | L LB PHARMACEUTICALS INC | $18M | 470.0K | 1.10% | — |
| 28 | B BECTON DICKINSON & CO | $17.9M | 100.0K | 1.09% | — |
| 29 | B BOSTON SCIENTIFIC CORP | $17.5M | 400.0K | 1.06% | — |
| 30 | E EDWARDS LIFESCIENCES CORP | $17.3M | 200.0K | 1.05% | — |
| 31 | E ERASCA INC | $16.6M | 1.13M | 1.01% | — |
| 32 | A ALKERMES PLC | $15.2M | 375.0K | 0.92% | — |
| 33 | M MEDTRONIC PLC | $15.1M | 175.0K | 0.92% | — |
| 34 | G GLAUKOS CORP | $14.8M | 90.0K | 0.90% | — |
| 35 | E ENCOMPASS HEALTH CORP | $14.6M | 120.0K | 0.89% | — |
| 36 | N NOVARTIS AG | $14.3M | 100.0K | 0.87% | — |
| 37 | A ABSCI CORPORATION | $14M | 1.30M | 0.85% | — |
| 38 | D QUEST DIAGNOSTICS INC | $12.8M | 55.0K | 0.78% | — |
| 39 | A ALTO NEUROSCIENCE INC | $12.8M | 500.0K | 0.77% | — |
| 40 | M MADRIGAL PHARMACEUTICALS INC | $12.6M | 25.0K | 0.76% | — |
| 41 | C BRISTOL-MYERS SQUIBB CO | $12.5M | 200.0K | 0.76% | — |
| 42 | E EDGEWISE THERAPEUTICS INC | $12.2M | 300.0K | 0.74% | — |
| 43 | Q UNIQURE NV | $12.1M | 500.0K | 0.73% | — |
| 44 | R RHYTHM PHARMACEUTICALS INC | $11.9M | 250.0K | 0.72% | — |
| 45 | T TEVA PHARMACEUTICAL INDS LTD | $11.9M | 300.0K | 0.72% | — |
| 46 | T TRAVERE THERAPEUTICS INC | $11.8M | 200.0K | 0.71% | — |
| 47 | P PRAXIS PRECISION MEDICINES I | $11.6M | 40.0K | 0.71% | — |
| 48 | L LIVANOVA PLC | $11.5M | 150.0K | 0.70% | — |
| 49 | W WATERS CORP | $11M | 25.0K | 0.67% | — |
| 50 | ? N/A SURROZEN INC | $10.5M | 325.0K | 0.63% | — |